John Overdeck’s GP-Act III Acquisition Corp GPAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-625,000
Closed -$6.78M 5512
2026
Q1
$6.78M Hold
625,000
0.01% 1724
2025
Q4
$6.68M Hold
625,000
0.01% 1441
2025
Q3
$6.63M Hold
625,000
0.01% 1236
2025
Q2
$6.59M Hold
625,000
0.01% 1065
2025
Q1
$6.43M Hold
625,000
0.01% 987
2024
Q4
$6.34M Hold
625,000
0.01% 963
2024
Q3
$6.3M Buy
+625,000
New +$6.26M 0.01% 960

Other funds holding GPAT

John Overdeck's GPAT Position: Q2 2026 in Review

John Overdeck sold out of GP-Act III Acquisition Corp (GPAT) in Q2 2026, closing a stake of 625,000 shares — an estimated $6.78M sold.

John Overdeck first reported a position in GPAT in Q3 2024 and held it in 7 quarters. The position peaked at $6.78M in Q1 2026. 24 funds tracked by Wall St. Rank hold GPAT as of Q2 2026.

  • John Overdeck reported no remaining GP-Act III Acquisition Corp position as of Q2 2026 after selling out during the quarter.
  • John Overdeck sold 625,000 GP-Act III Acquisition Corp shares in Q2 2026, an estimated $6.78M.
  • John Overdeck first reported a position in GP-Act III Acquisition Corp in Q3 2024 and held it in 7 quarters.
  • John Overdeck's GP-Act III Acquisition Corp position peaked at $6.78M in Q1 2026.
  • 24 funds tracked by Wall St. Rank held GP-Act III Acquisition Corp as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.